About HourGlass Technologies
HourGlass Technologies is a company based in Redwood City (United States) founded in 2007. HourGlass Technologies operates in a competitive market with competitors including Standard Bariatrics, Zeltiq, Nitinote Surgical, CoolSculpting and Modius Health, among others.
- Headquarter Redwood City, United States
- SectorsHealthcare
- Email••••••••
- Website hourglasstech.com
- Investors
Funding Insights of HourGlass Technologies
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of HourGlass Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in HourGlass Technologies
HourGlass Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Stanford Biodesign.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Project-based bio-design courses are offered to Stanford graduates and post-docs. | – | biodesign.stanford.edu | Stanford, United States |
Investor details for HourGlass Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HourGlass Technologies
2 dated milestones of HourGlass Technologies, from founding to its latest funding, stage changes and deals.
- Founded HourGlass Technologies is founded.
- Funding First funding round.
Competitors of HourGlass Technologies
HourGlass Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Standard Bariatrics, Zeltiq, Nitinote Surgical, CoolSculpting and Modius Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| standardbariatrics.com | 2014 | Cincinnati, United States | $35.5M | 34 | Medical devices for obesity surgical treatment are provided. | |
| zeltiq.com | 2005 | Pleasanton, United States | $70.42M | – | Controlled cooling technology is developed for non-surgical fat reduction. | |
| nitinotesurgical.com | 2014 | Ramat Gan, Israel | $26.1M | – | Non-surgical bariatric solutions for obesity are developed. | |
| coolsculpting.com | 2005 | Pleasanton, United States | – | 82 | Non-surgical fat reduction is achieved through controlled-cooling technology. | |
| modiushealth.com | 2017 | Belfast, United Kingdom | $1.59M | 21 | Non-invasive vestibular stimulation device for weight loss is offered. | |
| liposonix.com | 1999 | Hayward, United States | $37.94M | 6,139 | Non-surgical and non-invasive treatment to eliminate unwanted fat around waistline | |
| ultrashape.com | 2002 | Irvine, United States | $15M | – | Non-invasive fat cell destruction for body contouring | |
| cabochoninc.com | 2005 | Menlo Park, United States | $14.79M | – | Delivers an ultrasound system for disrupting subcutaneous tissue in medical applications. | |
| elememedical.com | 2007 | Merrimack, United States | – | – | Non-invasive laser and light therapy for cellulite reduction is provided. |
Detailed competitors of HourGlass Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to HourGlass Technologies
10 companies that operate in the same segment as HourGlass Technologies (Metabolic Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Developer of cortisol modulators for the treatment of various diseases | 1998 | Menlo Park, California, United States | – | USD 761.41 M | 500 | |
Developer of therapies for the treatment of endocrine-related diseases and cancers | 2008 | San Diego, California, United States | USD 103.5 M | USD 1.04 M | 437 | |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | 2009 | Cambridge, Massachusetts, United States | USD 685 M | – | 81 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Solutions for biomarker discovery and diagnostic testing are provided. | 2000 | Morrisville, United States | USD 165.87 M | – | – | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HourGlass Technologies
HourGlass Technologies was founded in 2007.
HourGlass Technologies is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Founded in 2007 and based in Redwood City, United States, HourGlass Technologies operates in the health technology sector. Focus is placed on medical devices for obesity treatment, including a patented transoral tool that enables weight loss without incisions. The procedure is designed for obese patients, with ongoing development of related solutions to address weight management needs.
HourGlass Technologies's top competitors include Nitinote Surgical, CoolSculpting and Standard Bariatrics.
HourGlass Technologies has 1 investor. Key investors include Stanford Biodesign.